Historical Background
Investigating the general phenomenon of “viral interference,” where the prior infection by one nonlethal virus might interfere with a subsequent infection of cells by a second virus, Isaacs, Lindenmann, and colleagues published a series of articles in 1957 showing that an inactivated influenza virus, reacting with cells of chick allantoic membrane, can elicit the secretion of a proteinaceous substance, “the interferon,” into the medium that can, when incubated with fresh cells, confer protection against viral infection on these cells (Isaacs and Lindenmann 1957). The next 20 years saw explorations of what types of cells could secrete “interferon,” what substances – viruses or chemical – could induce interferons and initial explorations of biological and therapeutic function. Heterogeneity of “interferon” was initially...
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Capobianchi MR, Uleri E, Caglioti C, Dolei A. Type I IFN family members: similarity, differences and interaction. Cytokine Growth Factor Rev. 2015;26:103–11. https://doi.org/10.1016/j.cytogfr.2014.10.011. PMID: 25466633.
Casanova JL, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity. 2012;36:515–28. https://doi.org/10.1016/j.immuni.2012.03.016. PMID: 22520845.
Crow MK, Olferiev M, Kirou KA. Targeting of Type I Interferon in Systemic Autoimmune Diseases. Transl Res. 2015;165:296–305. https://doi.org/10.1016/j.trsl.2014.10.005. PMCID: PMC4306610.
de Weerd NA, Samarajiwa SA, Hertzog PJ. Type I interferon receptors: biochemistry and biological functions. J Biol Chem. 2007;282:20053–7. https://doi.org/10.1074/jbc.R700006200. PMID: 17502368.
Duncan CJA, Mohamad SMB, Young DF, Skelton AJ, Leahy TR, et al. Human IFNAR2 deficiency: Lessons for antiviral immunity. Sci Transl Med. 2015;30:307ra154. https://doi.org/10.1126/scitranslmed.aac4227. PMCID: PMID: 26424569.
Fish EN, Platanias LC. Interferon receptor signaling in malignancy: A network of cellular pathways defining biological outcomes. Mol Cancer Res. 2014;12:1691–703. https://doi.org/10.1158/1541-7786.MCR-14-0450. PMID: 25217450.
Forster SC, Tate MD, Hertzog PJ. MicroRNA as Type I Interferon-regulated transcripts and modulators of the innate immune response. Front Immunol. 2015;6:334. https://doi.org/10.3389/fimmu.2015.00334. PMID: 26217335.
Hambleton S, Goodbourn S, Young DF, Dickinson P, Mohamad SM, et al. STAT2 deficiency and susceptibility to viral illness in humans. Proc Natl Acad Sci USA. 2013;110:3053–8. https://doi.org/10.1073/pnas.1220098110. PMID: 23391734.
Honda K, Takaoka A, Taniguchi T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity. 2006;25:349–60. https://doi.org/10.1016/j.immuni.2006.08.009. PMID: 16979567.
Honke N, Shaabani N, Zhang D-E, et al. Multiple functions of USP18. Cell Death and Disease. 2016;7;e2444. https://doi.org/10.1038/cddis.2016.326. PMID: 27809302.
Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci. 1957;147:258–67. Reprinted: J Immunol. 2015;195:1911-20. PMID: 26297790.
Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14:36–49. https://doi.org/10.1038/nri3581. PMID: 24362405.
Kotenko SV, Durbin, JE. Contribution of Type III interferons to antiviral immunity: Location, location, location. J Biol Chem. 2017 (epub ahead of publication) https://doi.org/10.1074/jbc.R117.777102
Langer JA, Cutrone EC, Kotenko S. The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev. 2004;15:33–48. PMID: 14746812.
Levy DE, Marié IJ, Durbin JE. Induction and function of type I and III interferon in response to viral infection. Curr Opin Virol. 2011;1:476–86. https://doi.org/10.1016/j.coviro.2011.11.001. PMCID: PMC3272644.
Mostafavi S, Yoshida H, Devapregasan M, et al. Parsing the interferon transcriptional network and its disease associations. Cell. 2016;164:564–78. https://doi.org/10.1016/j.cell.2015.12.032. PMID: 26824662.
Ng CT, Mendoza JL, Garcia KC, Oldstone MB. Alpha and beta type 1 interferon signaling: passage for diverse biologic outcomes. Cell. 2016;164:349–52. https://doi.org/10.1016/j.cell.2015.12.027. PMID: 26824652.
Pestka S. The interferons: 50 years after their discovery, there is much more to learn. J Biol Chem. 2007;282:20047–51. https://doi.org/10.1074/jbc.R700004200. PMID: 17502369.
Reich NC. STATS get their move on. JAKSTAT. 2013;2:e27080. https://doi.org/10.4161/jkst.27080. PMID: 24470978e27080.
Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: A complex web of host defenses. Annu Rev Immunol. 2014;32:513–45. https://doi.org/10.1146/annurev-immunol-032713-120231. PMID: 24555472.
Schreiber G, Piehler J. The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol. 2015;36:139–49. https://doi.org/10.1016/j.it.2015.01.002. PMID: 25687684.
Stark GR, Darnell Jr JE. The JAK-STAT pathway at twenty. Immunity. 2012;36:503–14. https://doi.org/10.1016/j.immuni.2012.03.013. PMCID: PMC3909993.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Langer, J.A. (2018). Type I Interferons. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_101827
Download citation
DOI: https://doi.org/10.1007/978-3-319-67199-4_101827
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67198-7
Online ISBN: 978-3-319-67199-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences